Becure Pharma

Bortezomib is a proteasome inhibitor used in the treatment of certain cancers, including multiple myeloma and mantle cell lymphoma. It works by inhibiting the proteasome, a complex that plays a key role in regulating various cellular processes such as the degradation of unwanted or damaged proteins. By blocking the proteasome, bortezomib causes the accumulation of abnormal proteins within cancer cells, which in turn triggers cell death (apoptosis) and inhibits tumor growth.

Bortezomib is administered as an injection, typically intravenously (IV) or subcutaneously (SC). It is often used in combination with other chemotherapy agents to enhance its therapeutic effects.

Abritiga 250mg Tablet should not be taken on an empty stomach. Taking it with food may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Abritiga 500mg Tablet should be taken on an empty stomach, either one hour before or at least two hours after a meal. Taking it with food may increase the blood levels of Abritiga 500mg Tablet, which may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.

Tasigna 150mg Capsule is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

Tasigna 150mg Capsule should be taken on an empty stomach, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Pegfilgrastim injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Pegfilgrastim injection (Neulasta, Stimufend, Udenyca, Ziextenzo) is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to bone marrow. Pegfilgrastim is in a class of medications called colony stimulating factors. It works by helping the body make more neutrophils.

Manufactured byM biotechMedicine brandAbiratonMedicine formTabletMedicine name abiraterone acetate tablets ipMedicine strength250 mgPackaging size120 tabletsSalt compositionAbiraterone acetate

Nilotinib is an oral chemotherapy medication that is classified as a tyrosine kinase inhibitor (TKI). It is primarily used for the treatment of Chronic Myelogenous Leukemia (CML), a type of cancer that affects the bone marrow and blood. Specifically, nilotinib is used for Philadelphia chromosome-positive (Ph+) CML in the chronic phase and accelerated phase, and for Ph+ CML in blast crisis when the disease is not responding to other treatments like imatinib.

Nilotinib works by selectively inhibiting the BCR-ABL fusion protein, which is produced by the Philadelphia chromosome in CML cells. This fusion protein is a tyrosine kinase that promotes cancer cell growth. By inhibiting BCR-ABL, nilotinib blocks the signals that drive the growth and survival of CML cells, thereby controlling the disease.

Eltrombopag is an oral thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) in various clinical conditions. It works by stimulating the thrombopoietin receptor (TPO-R), leading to the increased production of platelets in the bone marrow. It is mainly used in patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and chronic hepatitis C who require additional support to increase platelet counts.

Eltrombopag 50 mg tablets are used as part of the treatment for these conditions to help reduce the risk of bleeding associated with low platelet counts.

CARBOPLATIN 150MG INJECTION belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

CARBOPLATIN 150MG INJECTION contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.

Capecitabine is an oral chemotherapy drug used primarily in the treatment of cancer, particularly breast cancer and colorectal cancer. It is a prodrug, which means it is converted into its active form, 5-fluorouracil (5-FU), once inside the body. 5-FU is a potent chemotherapy agent that interferes with the ability of cancer cells to make DNA and RNA, ultimately inhibiting their growth and leading to cell death. Capecitabine is selectively activated in tumor tissue, which helps to reduce its effect on normal, healthy cells.

Capecitabine is typically used for the treatment of metastatic colorectal cancer, early-stage breast cancer, and gastric cancer (in some cases). It can be used alone or in combination with other chemotherapy agents.

Capecitabine is an oral chemotherapy medication that is used primarily for the treatment of certain types of cancer, including breast cancer, colorectal cancer, and gastric cancer. It is a prodrug, meaning that it is converted into its active form, 5-fluorouracil (5-FU), once inside the body. 5-FU is a powerful chemotherapy drug that inhibits the synthesis of DNA and RNA in cancer cells, preventing their growth and division.

Capecitabine Dispersible Tablets 500 mg are a formulation of capecitabine that can be dissolved in water for easier swallowing, which is especially useful for patients who have difficulty swallowing whole tablets. The dispersible form ensures that the drug is still effective while providing flexibility for patients who may have swallowing issues.

Olaparib is an oral medication used primarily in the treatment of certain types of cancer, specifically cancers with mutations in the BRCA (BReast CAncer gene) genes, which are associated with hereditary breast and ovarian cancers. It belongs to a class of drugs known as PARP inhibitors. PARP (Poly ADP Ribose Polymerase) is an enzyme that helps repair damaged DNA in cells. By inhibiting PARP, Olaparib prevents cancer cells from repairing their DNA, causing them to accumulate damage and ultimately leading to their death, while healthy cells can usually repair their DNA more effectively.

Olaparib Tablets 150 mg are typically used to treat ovarian cancer, breast cancer, and certain other cancers, particularly in patients who have mutations in the BRCA1 or BRCA2 genes, which impair their ability to repair DNA damage.

Pazopanib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of certain cancers. It works by inhibiting the activity of multiple receptors involved in the growth of cancer cells, including those related to vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and c-Kit, which are involved in tumor growth, angiogenesis (formation of new blood vessels), and metastasis.

Pazopanib is primarily used to treat renal cell carcinoma (RCC), a type of kidney cancer, and soft tissue sarcoma (STS), a group of cancers that arise from soft tissues such as muscles, fat, and connective tissues. It may also be used in combination with other therapies or as a second-line treatment in cases where other options have failed.

Dasatib 100mg Tablet can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.